Joel Greenblatt's NVO Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 4,758 shares of Novo Nordisk A/S (NVO) worth $228,099, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in NVO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 4,758 shares. Largest reduction occurred in Q1 2026, reducing 3,987 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +4,758 | New Buy | 4,758 | $47.94 |
| Q1 2026 | -3,987 | Sold Out | 0 | $0.00 |
| Q4 2025 | +3,987 | New Buy | 3,987 | $50.88 |
Joel Greenblatt's Novo Nordisk A/S Investment FAQs
Joel Greenblatt first purchased Novo Nordisk A/S (NVO) in Q4 2025, acquiring 3,987 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Novo Nordisk A/S (NVO) for 3 quarters since Q4 2025.
Joel Greenblatt's largest addition to Novo Nordisk A/S (NVO) was in Q2 2026, adding 4,758 shares worth $228,099.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 4,758 shares of Novo Nordisk A/S (NVO), valued at approximately $228,099.
As of the Q2 2026 filing, Novo Nordisk A/S (NVO) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Novo Nordisk A/S (NVO) was 4,758 shares, as reported at the end of Q2 2026.